Archives
-
Acetylcholine Chloride: Pioneering Gut-Brain Translational R
2026-06-04
Explore how Acetylcholine Chloride from APExBIO empowers translational researchers to mechanistically interrogate cholinergic signaling in the gut-brain axis, highlighting its role in antiseizure strategies for pediatric epilepsy and offering actionable guidance for assay design, protocol optimization, and cross-disciplinary impact.
-
Angiotensin II (A1042): Practical Guide for Vascular Researc
2026-06-03
Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) provides a reproducible platform for investigating hypertension mechanisms, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy. It is not intended for diagnostic or therapeutic use, and should be deployed strictly in research settings following product-dossier-backed workflow guidance.
-
Reelin Signaling Is Required for Ketamine’s Antidepressant A
2026-06-03
This study establishes that intact synaptic Reelin-Apoer2-SFK signaling is essential for ketamine’s rapid antidepressant and synaptic effects in the hippocampus. Disruption of this pathway abolishes ketamine-induced synaptic potentiation and behavioral responses, providing mechanistic insight into nonresponsiveness in treatment-resistant depression.
-
XAV-939: From Wnt Pathway Modulation to Cardiac Reprogrammin
2026-06-02
Explore how XAV-939 (NVP-XAV939) advances beyond canonical Wnt/β-catenin pathway inhibition to enable next-generation direct cardiac reprogramming and precision disease modeling. This in-depth analysis integrates mechanistic insight, protocol optimization, and the latest translational research.
-
5-Aminolevulinic acid HCl: Heme Biosynthesis & Research Uses
2026-06-02
5-Aminolevulinic acid HCl is a high-purity, water-soluble intermediate essential for heme biosynthesis and widely used in cancer and microbial virulence research. Its precise role in modulating porphyrin levels and pathogen immune evasion is supported by robust evidence. The product from APExBIO enables standardized workflows and advanced photodynamic therapy applications.
-
Deep Learning Identifies Cardiotoxicity in iPSC-CM Screens
2026-06-01
Grafton et al. (2021) introduce a scalable approach by leveraging deep learning with high-content imaging of iPSC-derived cardiomyocytes to robustly detect drug-induced cardiotoxicity. This method provides a phenotypic screening platform that advances early-stage drug safety assessment and informs the use of reference compounds such as Cisapride (R 51619) in predictive cardiac research.
-
VER 155008: Precision HSP 70 Inhibition for Cancer Assays
2026-06-01
Explore how VER 155008, a potent HSP 70 inhibitor, enables advanced apoptosis and cancer proliferation assays. This article offers a unique, protocol-driven perspective on leveraging Hsp70 ATPase inhibition for high-impact cancer research.
-
Applied Use of α-Linolenic Acid in Lipid Metabolism Research
2026-05-31
Harnessing α-Linolenic Acid (ALA) unlocks precision in dissecting lipid metabolism, cardiovascular function, and immunomodulation in both cellular and animal models. This guide details robust workflows, troubleshooting strategies, and translational insights for researchers leveraging ALA from APExBIO.
-
InstaBlue Protein Stain Solution: Fast, Sensitive Protein Ge
2026-05-30
Accelerate your protein electrophoresis analysis with InstaBlue Protein Stain Solution—a rapid, non-toxic, and mass spectrometry-compatible reagent. Its ultra-fast protocol and high sensitivity are setting new standards for biomedical research and quantitative protein workflows.
-
Future-Proofing Stem Cell Assays: Ethacridine and Epigenetic
2026-05-29
This thought-leadership article explores how Ethacridine lactate monohydrate, a high-purity aromatic antiseptic compound, underpins the reproducibility and translational relevance of advanced stem cell and chromatin studies. Integrating recent mechanistic insights into super-enhancer regulation by YAP-TEAD, we provide actionable protocol guidance and strategic perspective for researchers navigating the evolving landscape of microbial control in cell fate and regenerative workflows.
-
Patient-Derived 3D Spheroid Models for Organ-Confined Prosta
2026-05-29
This study establishes robust three-dimensional spheroid cultures from radical prostatectomy specimens, providing a translationally relevant in vitro model for organ-confined prostate cancer. The work highlights the model’s capacity for long-term viability, molecular fidelity, and drug response evaluation—addressing longstanding gaps in prostate cancer research.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina
2026-05-28
The referenced study uncovers a novel mechanism by which Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) triggers ferroptosis in triple-negative breast cancer (TNBC) through CUL3-mediated ubiquitination of MTDH. These findings provide a mechanistic framework for leveraging Gramine as a precision tool in cancer biology research targeting ferroptosis and ubiquitination pathways.
-
Deep Learning for Cardiotoxicity Detection in iPSC-CMs
2026-05-28
This article examines how deep learning was applied to high-content imaging of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to identify drug-induced cardiotoxicity. The study demonstrates a scalable approach to predict cardiac safety liabilities early in drug discovery, offering a technical advance for phenotypic screening workflows.
-
RAS/PI3K Mutations Enhance Sensitivity to PARP/NAMPT Inhibit
2026-05-27
The reference study demonstrates that epithelial ovarian cancer cells with RAS/PI3K pathway mutations are highly susceptible to combined PARP and NAMPT inhibition. This synergy is mechanistically linked to intensified NAD+ depletion, DNA damage, and apoptosis, offering a rationale for biomarker-driven combination therapies in resistant ovarian cancer.
-
D-Luciferin Sodium Salt: Optimizing Firefly Luciferase Assay
2026-05-27
D-Luciferin sodium salt empowers highly sensitive, non-invasive bioluminescence workflows for real-time cell viability and metabolism monitoring. This article breaks down advanced protocol enhancements, troubleshooting strategies, and translational oncology use-cases, including a deep dive into CAR macrophage immunotherapy models.
663 records 9/45 page Previous Next First page 上5页 678910 下5页 Last page